Literature DB >> 8484454

Treatment for glaucoma: adherence by the elderly.

J H Gurwitz1, R J Glynn, M Monane, D E Everitt, D Gilden, N Smith, J Avorn.   

Abstract

OBJECTIVES: The purpose of this study was to determine the extent of nonadherence to treatment for glaucoma among elderly patients.
METHODS: This was a retrospective cohort study of 2440 patients older than age 65 who were enrolled in the New Jersey Medicaid Program and who were newly initiated on a topical agent for the treatment of glaucoma. Two patient-specific measures of nonadherence were employed: (1) no filled prescription for any glaucoma medication over a 12-month period after the initiation of therapy and (2) number of days without therapy for glaucoma during this 12-month period.
RESULTS: By the first measure, 569 patients (23%) were found to be nonadherent. The mean number of days without therapy during the study year was 112. Factors associated with nonadherence included the use of glaucoma medication requiring more than 2 administrations per day and the presence of multiple other medications in the patient's drug regimen. Patients started on multiple glaucoma medication were more adherent than those started on a single agent. Age and sex were not found to be predictors of nonadherence.
CONCLUSIONS: Substantial nonadherence was found to be common in this population. More attention to the issue of nonadherence could result in important benefits in the preservation of sight.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8484454      PMCID: PMC1694682          DOI: 10.2105/ajph.83.5.711

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  23 in total

1.  Compliance and prognosis in glaucoma.

Authors:  M A Kass
Journal:  Arch Ophthalmol       Date:  1985-04

2.  Medicaid records as a valid data source: the Tennessee experience.

Authors:  C F Federspiel; W A Ray; W Schaffner
Journal:  Med Care       Date:  1976-02       Impact factor: 2.983

3.  Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing".

Authors:  J Avorn; S B Soumerai
Journal:  N Engl J Med       Date:  1983-06-16       Impact factor: 91.245

Review 4.  Understanding and improving patient compliance.

Authors:  S A Eraker; J P Kirscht; M H Becker
Journal:  Ann Intern Med       Date:  1984-02       Impact factor: 25.391

5.  Improving antibiotic prescribing in office practice. A controlled trial of three educational methods.

Authors:  W Schaffner; W A Ray; C F Federspiel; W O Miller
Journal:  JAMA       Date:  1983-10-07       Impact factor: 56.272

6.  Monitoring compliance with pilocarpine therapy.

Authors:  S E Norell
Journal:  Am J Ophthalmol       Date:  1981-11       Impact factor: 5.258

7.  Patient compliance in glaucoma.

Authors:  S Bloch; A R Rosenthal; L Friedman; P Caldarolla
Journal:  Br J Ophthalmol       Date:  1977-08       Impact factor: 4.638

8.  Incidence estimates for lens changes, macular changes, open-angle glaucoma and diabetic retinopathy.

Authors:  M J Podgor; M C Leske; F Ederer
Journal:  Am J Epidemiol       Date:  1983-08       Impact factor: 4.897

9.  Progression of visual field defects in glaucoma. Relation to compliance with pilocarpine therapy.

Authors:  P A Granström
Journal:  Arch Ophthalmol       Date:  1985-04

Review 10.  The problem of non-compliance with drug therapy.

Authors:  L Evans; M Spelman
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546

View more
  68 in total

1.  Patients prefer once-daily glaucoma drops.

Authors:  Alex J Buller; Laurence H Morgan; Brian L Hercules
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02       Impact factor: 3.117

2.  Glaucoma patient expression of medication problems and nonadherence.

Authors:  Catherine Slota; Robyn Sayner; Michelle Vitko; Delesha M Carpenter; Susan J Blalock; Alan L Robin; Kelly W Muir; Mary Elizabeth Hartnett; Betsy Sleath
Journal:  Optom Vis Sci       Date:  2015-05       Impact factor: 1.973

3.  Patterns of Glaucoma Medication Adherence over Four Years of Follow-Up.

Authors:  Paula Anne Newman-Casey; Taylor Blachley; Paul P Lee; Michele Heisler; Karen B Farris; Joshua D Stein
Journal:  Ophthalmology       Date:  2015-08-25       Impact factor: 12.079

4.  The influence of health literacy level on an educational intervention to improve glaucoma medication adherence.

Authors:  Kelly W Muir; Alice Ventura; Sandra S Stinnett; Abraham Enfiedjian; R Rand Allingham; Paul P Lee
Journal:  Patient Educ Couns       Date:  2011-10-13

5.  Accuracy and performance of a commercially available Dosing Aid.

Authors:  Tara H Cronin; Malik Y Kahook; Kira L Lathrop; Robert J Noecker
Journal:  Br J Ophthalmol       Date:  2006-08-17       Impact factor: 4.638

6.  Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients.

Authors:  Christine M G Olthoff; Juliette G M M Hoevenaars; Bart W van den Borne; Carroll A B Webers; Jan S A G Schouten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-19       Impact factor: 3.117

7.  Glaucoma severity and medication adherence in a county hospital population.

Authors:  Cindy Ung; Elisa Zhang; Tatyana Alfaro; Yohko Murakami; Monica Zhang; Michael I Seider; Shan C Lin; Kuldev Singh
Journal:  Ophthalmology       Date:  2013-02-28       Impact factor: 12.079

8.  Intraocular pressure after replacement of current dual therapy with latanoprost monotherapy in patients with open angle glaucoma.

Authors:  L E Pillunat; L-I Larsson
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

9.  An assessment of the tolerability of moxifloxacin 0.5% compared to azithromycin 1.0% in DuraSite.

Authors:  David Granet; Steven J Lichtenstein; Bruce Onofrey; James A Katz
Journal:  Clin Ophthalmol       Date:  2007-12

10.  Patient persistence with first-line antiglaucomatous monotherapy.

Authors:  Alfonso Arias; Konrad Schargel; Fernando Ussa; Maria I Canut; Amelia Y Belén Robles; Belén Martí Sánchez
Journal:  Clin Ophthalmol       Date:  2010-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.